Immunophilins: beyond immunosuppression.
Hamilton
G S
GS
Department of Research, Guilford Pharmaceuticals, Inc., 6611 Tributary Street, Baltimore, Maryland 21224, USA.
Steiner
J P
JP
D000818:Animals; D001665:Binding Sites; D016572:Cyclosporine / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D020104:Immunophilins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D007166:Immunosuppressive Agents / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D008968:Molecular Conformation; D009416:Nerve Regeneration / Q000187:drug effects; D009420:Nervous System / Q000187:drug effects / Q000201:enzymology*; D011487:Protein Conformation; D020123:Sirolimus / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D016559:Tacrolimus / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D022021:Tacrolimus Binding Proteins
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D022021:Tacrolimus Binding Proteins; D020104:Immunophilins; D020123:Sirolimus; D016559:Tacrolimus